Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | WHWKWhitehawk Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $7.15M |
| Revenue, yoy | −72.5% |
| Net income | $20.60M |
| Net income, yoy | +67.7% |
| Net margin | -288.3% |
| Free cash flow | $97.99M |
| FCF margin | -1,371.4% |
| EPS, diluted | $0.33 |
Add another company.